Article Details

EMA to evaluate Roche arthritis drug RoActemra for severe COVID-19 - PMLiVE

Retrieved on: 2021-08-17 10:52:30

Tags for this article:

Click the tags to see associated articles and topics

EMA to evaluate Roche arthritis drug RoActemra for severe COVID-19 - PMLiVE. View article details on HISWAI: https://www.pmlive.com/pharma_news/ema_to_evaluate_roche_arthritis_drug_roactemra_for_severe_covid-19_1375209

Excerpt

The European Medicines Agency (EMA) has started evaluating Roche's anti-inflammatory medicine RoActemra (tocilizumab) to extend its potential ...

Article found on: www.pmlive.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up